Volume 62, Issue 4, Pages (October 2002)

Slides:



Advertisements
Similar presentations
Volume 66, Issue 4, Pages (October 2004)
Advertisements

A.M. Thompson, T.G. Pickering  Kidney International 
Reduced renal function in patients with simple renal cysts
Volume 56, Pages S238-S241 (July 1999)
Melamine toxicity: one more culprit in calcium kidney lithiasis
Volume 54, Issue 3, Pages (September 1998)
Volume 57, Issue 5, Pages (May 2000)
KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient  Christoph Wanner,
Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis  James F. Medcalf, Kevin P.G.
Volume 83, Issue 3, Pages (March 2013)
Peter Hurley, Suma Konety, Qing Cao, Daniel Weisdorf, Anne Blaes 
Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients  Demetrios J. Kutsogiannis, R.T.Noel.
Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes  Robert W. Schrier, Raymond.
Prehypertension and chronic kidney disease: the ox or the plow?
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population  Mark J. Sarnak, Bertrand L. Jaber  Kidney International 
Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?  Fu L. Luan, Diane E. Steffick,
Steven J. Chadban, Natalie D. Staplin  Kidney International 
Prediction of hypertension in chronic hemodialysis patients
Progression of diabetic nephropathy
Volume 74, Issue 3, Pages (August 2008)
Renal risk scores: Progress and prospects
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Volume 87, Issue 2, Pages (February 2015)
Study of Heart and Renal Protection (SHARP)
Melamine toxicity: one more culprit in calcium kidney lithiasis
Blood pressure targets in hemodialysis patients
Sabina Kersting, Ronald J. Hené, Hein A. Koomans, Leo F. Verdonck 
Volume 62, Issue 1, Pages (July 2002)
Volume 78, Issue 8, Pages (October 2010)
Should kidney donors be genotyped for APOL1 risk alleles?
Volume 89, Issue 5, Pages (May 2016)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
J.M. van den Akker, J.F.M. Wetzels, A.J. Hoitsma  Kidney International 
Volume 87, Issue 1, Pages (January 2015)
Volume 67, Issue 4, Pages (April 2005)
Reduced renal function in patients with simple renal cysts
Counteracting progression of renal disease: A look into the future
Volume 56, Issue 5, Pages (November 1999)
Volume 86, Issue 3, Pages (September 2014)
Volume 81, Issue 4, Pages (February 2012)
Circadian regulation of renal function
Peter J. Conlon, Mark A. Little, Karen Pieper, Daniel B. Mark 
Volume 64, Issue 2, Pages (August 2003)
Serum cystatin C-immunoglobulin high-molecular-weight complexes in kidney and liver transplant patients  Jesús Hermida, Rafael Romero, J. Carlos Tutor 
Volume 67, Issue 2, Pages (February 2005)
Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors  Barry M. Brenner, Joann Zagrobelny 
Organ transplantation goes to the movies
Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant  Chirag R. Parikh, Peter Mcsweeney,
Does equal care give equal outcomes?
Volume 62, Issue 4, Pages (October 2002)
Stephen P. Mcdonald, Graeme R. Russ  Kidney International 
Volume 80, Issue 10, Pages (November 2011)
Volume 56, Pages S238-S241 (July 1999)
Volume 64, Issue 4, Pages (October 2003)
Charles A. Herzog  Kidney International 
Importance of blood pressure control in hemodialysis patient survival
Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa 
Volume 55, Issue 2, Pages (February 1999)
Volume 70, Issue 5, Pages (September 2006)
Volume 64, Issue 4, Pages (October 2003)
The international realities of live donor kidney transplantation
Evaluation of the Losartan in Hemodialysis (ELHE) Study
Volume 66, Issue 4, Pages (October 2004)
Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga 
Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis  Nauman Siddiqi, Maureen A. McBride,
Volume 57, Issue 2, Pages (October 2000)
Lipoprotein abnormalities in diabetic nephropathy
Volume 57, Pages S44-S48 (April 2000)
Ronen Levi, Justin Silver  Kidney International 
Presentation transcript:

Volume 62, Issue 4, Pages 1440-1446 (October 2002) Patient survival after renal transplantation: IV. Impact of post-transplant diabetes  Fernando G. Cosio, Todd E. Pesavento, Sunny Kim, Kwame Osei, Mitchell Henry, Ronald M. Ferguson  Kidney International  Volume 62, Issue 4, Pages 1440-1446 (October 2002) DOI: 10.1111/j.1523-1755.2002.kid582.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Evolution of serum lipids concentrations the first six years after kidney transplantation. (A) Total serum cholesterol levels (mean ± SEM) in the following groups of patients: no diabetes (NoDM; □—□); with diabetes (DM; •…•); post-transplant diabetes (PTDM; ▴—▴). (B) Serum triglyceride (TG) levels (mean ± SEM) in the same groups of patients. Kidney International 2002 62, 1440-1446DOI: (10.1111/j.1523-1755.2002.kid582.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Serum TG levels in NoDM (□) and PTDM (•) patients before they became diabetic. Data are mean ± SEM. Values represent means and standard errors of the mean. By Wilcoxon: year 1, P = 0.015; years 2 and 3, P < 0.0001; year 4, P = 0.001. Kidney International 2002 62, 1440-1446DOI: (10.1111/j.1523-1755.2002.kid582.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Changes in blood pressure (BP) levels during the first six years after kidney transplantation. (A) Systolic BP, (B) diastolic BP, and (C) pulse pressure in the three groups of patients, NoDM (□—□), DM (•…•) and PTDM (▴—▴). Data are mean ± SEM. Kidney International 2002 62, 1440-1446DOI: (10.1111/j.1523-1755.2002.kid582.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 4 Kaplan-Meier patient survival in the three study groups: NoDM (thin line), DM (thick line) and PTDM (dashed line). (A) Survival was calculated from the day of transplantation in all three groups of patients. (B) Survival for PTDM was calculated from the time of development of diabetes and for the other two groups from the day of transplantation. Kidney International 2002 62, 1440-1446DOI: (10.1111/j.1523-1755.2002.kid582.x) Copyright © 2002 International Society of Nephrology Terms and Conditions